Flash Finance

Bayer CropScience LimitedBAYERCROPCorporate

Basic Materials Agricultural Inputs Latest results: Jun 2026 14 quarters of data
Consolidated Standalone
₹3,638.80
MCap ₹16,354 Cr · P/E 22.3
Bayer CropScience Limited — Stock analysis & AI research Bayer CropScience Limited — Seasonality — best & worst months Bayer CropScience Limited — Technical indicators & charts Bayer CropScience Limited — Technical setup — score, trend, support & resistance Bayer CropScience Limited — Falling Wedge pattern forming Bayer CropScience Limited — Live exchange announcements
📋 High ROE Stocks📋 High ROCE Stocks📋 High Interest Coverage Stocks📋 High Dividend Yield Stocks📋 Low Debt Stocks📋 High Promoter Holding Stocks 📈 MACD Bullish Crossover📈 Multi-Timeframe Bearish Stocks 🏭 Chemicals sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹1,835 Cr
Sales · Jun 2026
-4.2% YoY
₹368 Cr
Operating Profit · Jun 2026
+5.7% YoY
20.1%
OPM % · Jun 2026
+10.4% YoY
₹322 Cr
Net Profit · Jun 2026
+15.4% YoY
₹71.56
EPS · Jun 2026
+15.4% YoY

📝 Bayer CropScience Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Bayer CropScience Limited reported revenue of ₹1,835 crore for the quarter ended June 2026 (Q1 FY27), down 4.2% from ₹1,915 crore in the same quarter last year, and up 66.7% sequentially over the March 2026 quarter.

Net profit rose 15.4% year-on-year to ₹322 crore, from ₹279 crore. Earnings per share (EPS) came in at ₹71.56.

Operating profit stood at ₹368 crore — an operating margin (OPM) of 20.1%, compared with 18.2% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Bayer CropScience Limited posted revenue of ₹5,675 crore, a growth of 3.7% over FY25, with a net profit of ₹690 crore (up 21.7% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹5,595 crore with a net profit of ₹733 crore.

Valuation snapshot

At the current price of ₹3,638.80, BAYERCROP has a market capitalisation of ₹16,354 crore and a trailing P/E of about 22.3.

Within the Agricultural Inputs industry, it is the 6th-largest of the 9 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 71.44%, foreign institutional investors (FIIs) 3.89%, domestic institutional investors (DIIs) 11.89%, public shareholders 12.79% of Bayer CropScience Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹16,354 Cr
Current Price ?
₹3,638.8
P/E ?
22.31below ind
Industry P/E ?
22.40
P/B ?
5.51
P/S ?
2.92
P/FCF ?
16.13
Enterprise Value ?
₹16,436 Cr
EV/EBITDA ?
18.40
PEG ?
22.31
Earnings Yield ?
4.7%
Dividend Yield ?
3.42%
Profitability & Returns
Sales (TTM) ?
₹5,595 Cr
OPM ?
16.0%
Profit after tax (TTM) ?
₹733 Cr
EPS (TTM) ?
₹163.10
ROCE ?
29.0%
ROE ?
24.7%
ROA ?
12.9%
Growth
Sales — latest qtr ?
₹1,835 Cr
PAT — latest qtr ?
₹322 Cr
YoY qtr sales growth ?
-4.2%
YoY qtr profit growth ?
15.4%
Sales growth (3y) ?
3%
Sales growth (5y) ?
6%
Profit growth (3y) ?
1%
Profit growth (5y) ?
7%
Financial Health
Debt ?
₹82 Cr
Debt to Equity ?
0.03
Interest Coverage ?
39.0
Current Ratio ?
N/A
Ownership
Promoter holding ?
71.44%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
-14.1%
Return 6 months ?
-25.7%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 9821,7401,6179557921,6311,7381,0571,0461,9151,5531,1061,1011,835 -4.2% +66.7%
Operating Profit 2064253051289731418420171348205117203368 +5.7% +81.3%
Other Income 2421161529272432371914164789 +368.4% +89.4%
Interest 78435434654564 -20.0% -33.3%
Depreciation 2731121516221415342714153850 +85.2% +31.6%
Profit Before Tax 19540630612410531619034168335200113206402 +20.0% +95.1%
Net Profit 15832822393962541363414327915396162322 +15.4% +98.8%
EPS 35.2773.0949.6020.7221.3656.5630.337.6131.8962.0133.9821.2936.0771.56 +15.4% +98.4%
OPM % 21.0% 24.4% 18.9% 13.4% 12.2% 19.3% 10.6% 1.9% 16.3% 18.2% 13.2% 10.6% 18.4% 20.1% +10.4% +9.2%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹5,472 Cr ₹5,675 Cr ₹5,595 Cr +3.7%
Operating Profit ₹689 Cr ₹873 Cr ₹893 Cr +26.7%
OPM % 12.59% 15.38% 15.96% +22.2%
NPM % 10.36% 12.16% 13.10% +17.4%
Other Income ₹120 Cr ₹96 Cr ₹166 Cr -20.0%
Depreciation ₹85 Cr ₹94 Cr ₹117 Cr +10.6%
Interest ₹17 Cr ₹20 Cr ₹19 Cr +17.6%
EBIT ₹604 Cr ₹779 Cr ₹776 Cr +29.0%
PBT ₹708 Cr ₹854 Cr ₹921 Cr +20.6%
Tax — — — —
Net Profit ₹567 Cr ₹690 Cr ₹733 Cr +21.7%
EPS ₹126.39 ₹153.35 ₹162.90 +21.3%
Material Cost — — — —
Employee Cost — — — —
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 45454545 +0.0%
Reserves 2,6672,8042,8062,921 +4.1%
Borrowings 744710582 -21.9%
Other Liabilities 1,8931,7012,2902,652 +15.8%
Total Liabilities 4,6794,5975,2465,699 +8.6%
Fixed Assets 462414470581 +23.6%
CWIP 1091191195 -95.8%
Investments 41543557 +62.9%
Other Assets 4,0664,0104,6225,056 +9.4%
Total Assets 4,6794,5975,2465,699 +8.6%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 6099522621,078 +311.5%
Cash from Investing Activity 8308672 -16.3%
Cash from Financing Activity -613-656-619-624 -0.8%
Net Cash Flow 79296-272527 +293.8%
Free Cash Flow 5379122221,014 +356.8%
CFO/OP 92%113%61%142% +132.8%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 69696372 +14.3%
Inventory Days 268222319231 -27.6%
Days Payable 12987148134 -9.5%
Cash Conversion Cycle 208204234169 -27.8%
Working Capital Days 86788860 -31.8%
ROCE % 34%34%25%29% +16.0%

👥 Shareholding (latest 4 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026 % Chg
Promoters 71.44%71.44%71.44%71.44% +0.0%
FIIs 3.64%3.80%3.84%3.89% +1.3%
DIIs 11.38%11.22%11.47%11.89% +3.7%
Public 13.55%13.56%13.27%12.79% -3.6%
No. of Shareholders 55,75358,10958,57155,795 -4.7%

⚖️ Peer comparison

Industry: Agricultural Inputs · 9 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 COROMANDEL Coromandel International ₹1,934.90 56,991 24.7 31,480 1,898 10.2% 6.0% 30.7% -7.6% 20.4% -80.1%
2 FACT Fertilisers and Chemicals ₹779.90 50,465 — 5,934 -106 0.3% -1.8% 41.3% -196.0% 20.2% -1547.2%
3 UPL UPL ₹550.60 46,541 29.1 42,797 1,951 16.4% 4.6% -10.3% 125.4% 10.5% 58.5%
4 PIIND PI Industries ₹2,259.00 34,270 25.9 6,714 1,320 25.3% 19.7% -15.8% -20.5% -12.4% -39.5%
5 SUMICHEM Sumitomo Chemical ₹476.05 23,762 41.0 3,245 579 21.1% 17.9% 2.9% 7.1% 0.6% 20.5%
6 BAYERCROP Bayer CropScience ₹3,985.60 17,912 24.5 5,595 733 16.0% 13.1% 3.7% 21.7% -4.2% 15.4%
7 CHAMBLFERT Chambal Fertilisers ₹419.40 16,803 8.7 20,123 1,928 13.8% 9.6% 24.9% 18.4% -11.8% -4.6%
8 PARADEEP Paradeep Phosphates ₹156.20 16,222 15.1 23,447 1,073 9.8% 4.6% 52.5% 69.5% 63.1% 53.1%
9 EIDPARRY E.I.D.- Parry ₹722.95 12,865 23.1 38,836 1,228 8.7% 3.2% 52.3% 3.5% 3.4% -32.8%
❓ Frequently asked questions
What was Bayer CropScience Limited's revenue in Q1 FY27?
Bayer CropScience Limited reported revenue of ₹1,835 crore for the quarter ended June 2026 (Q1 FY27), down 4.2% from ₹1,915 crore in the same quarter last year, and up 66.7% sequentially over the March 2026 quarter.
What was Bayer CropScience Limited's net profit in Q1 FY27?
Net profit rose 15.4% year-on-year to ₹322 crore, from ₹279 crore. Earnings per share (EPS) came in at ₹71.56.
What is BAYERCROP's market capitalisation and P/E ratio?
At the current price of ₹3,638.80, BAYERCROP has a market capitalisation of ₹16,354 crore and a trailing P/E of about 22.3.
Who owns Bayer CropScience Limited? (shareholding pattern)
As of Mar 2026, promoters held 71.44%, foreign institutional investors (FIIs) 3.89%, domestic institutional investors (DIIs) 11.89%, public shareholders 12.79% of Bayer CropScience Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI